CHGCY vs ABBV: Which Stock is Better?
Side-by-side comparison of Chugai Pharmaceutical Co Ltd ADR and Abbvie Inc in 2026
CHGCY
Chugai Pharmaceutical Co Ltd ADR
$32.11
ABBV
Abbvie Inc
$208.99
Key Metrics Comparison
| Metric | CHGCY | ABBV | Winner |
|---|---|---|---|
| Market Cap | $101.69B | $368.65B | ABBV |
| P/E Ratio | 35.73 | 87.57 | CHGCY |
| EPS (TTM) | $0.86 | $2.38 | ABBV |
| Revenue Growth | 0.1% | 0.1% | CHGCY |
| Gross Margin | 71.1% | 71.6% | ABBV |
Analyze CHGCY
Full quant analysis
Analyze ABBV
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHGCY or ABBV a better investment?
Comparing CHGCY and ABBV: Chugai Pharmaceutical Co Ltd ADR has a market cap of $101.69B while Abbvie Inc has $368.65B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHGCY and ABBV?
CHGCY (Chugai Pharmaceutical Co Ltd ADR) and ABBV (Abbvie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHGCY or ABBV?
Based on P/E ratios, CHGCY trades at a lower multiple (35.7x vs 87.6x).
Which is growing faster: CHGCY or ABBV?
CHGCY has higher revenue growth at 0.1% vs 0.1% for ABBV.
Which company is more profitable: CHGCY or ABBV?
Abbvie Inc (ABBV) has higher gross margins at 71.6% compared to 71.1% for CHGCY.
Which is the larger company: CHGCY or ABBV?
Abbvie Inc (ABBV) is larger with a market cap of $368.65B compared to $101.69B for CHGCY.
Should I buy CHGCY or ABBV in 2026?
Both CHGCY and ABBV have investment merit. CHGCY trades at $32.11 while ABBV trades at $208.99. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHGCY and ABBV stock?
Key differences: Market Cap ($101.69B vs $368.65B), P/E Ratio (35.7x vs 87.6x), Revenue Growth (0.1% vs 0.1%), Gross Margin (71.1% vs 71.6%).